Intellia Therapeutics
NTLA
#4597
Rank
โ‚ฌ1.57 B
Marketcap
15,50ย โ‚ฌ
Share price
4.56%
Change (1 day)
-33.76%
Change (1 year)

Revenue for Intellia Therapeutics (NTLA)

Revenue in 2024 (TTM): โ‚ฌ42.87 Million

According to Intellia Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚ฌ42.58 Million. In 2023 the company made a revenue of โ‚ฌ32.81 Million a decrease over the revenue in the year 2022 that were of โ‚ฌ48.58 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Intellia Therapeutics from 2015 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚ฌ42.87 M30.66%
2023 โ‚ฌ32.81 M-32.47%
2022 โ‚ฌ48.58 M66.48%
2021 โ‚ฌ29.18 M-38.1%
2020 โ‚ฌ47.14 M22.54%
2019 โ‚ฌ38.47 M44.63%
2018 โ‚ฌ26.6 M22.22%
2017 โ‚ฌ21.76 M38.94%
2016 โ‚ฌ15.66 M183.42%
2015 โ‚ฌ5.52 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA